StockMacro
Menu

LENZ Therapeutics

LENZ on XNAS, LENZ Therapeutics, Inc.

Measures activity, not value. Not investment advice.

News, last 7 days Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

4

2.7× its usual week

Usual week The median week of the 26 weeks before the last 7 days. Weeks without an article count as 0.

1.5

articles

Last 12 months

89

articles; 114 stored in all

Publishers, 12 months

35

most from Yahoo Finance (15%)

4 articles in the last 7 days, 2.7× its usual week (1.5).

Articles per week by publish date, last 12 months; each bar is 7 days, the last one ends now. Dashed: the usual week.

See the numbers
Week to 22 Nov 2026: 4 articles
Week to 15 Nov 2026: 2 articles
Week to 8 Nov 2026: 5 articles
Week to 1 Nov 2026: 12 articles
Week to 25 Oct 2026: 3 articles
Week to 18 Oct 2026: 2 articles
Week to 11 Oct 2026: 1 article
Week to 4 Oct 2026: 2 articles
Week to 27 Sep 2026: 9 articles
Week to 20 Sep 2026: 1 article
Week to 13 Sep 2026: 1 article
Week to 6 Sep 2026: 3 articles
Week to 30 Aug 2026: 0 articles
Week to 23 Aug 2026: 1 article
Week to 16 Aug 2026: 9 articles
Week to 9 Aug 2026: 2 articles
Week to 2 Aug 2026: 0 articles
Week to 26 Jul 2026: 0 articles
Week to 19 Jul 2026: 3 articles
Week to 12 Jul 2026: 3 articles
Week to 5 Jul 2026: 0 articles
Week to 28 Jun 2026: 2 articles
Week to 21 Jun 2026: 0 articles
Week to 14 Jun 2026: 0 articles
Week to 7 Jun 2026: 1 article
Week to 31 May 2026: 0 articles
Week to 24 May 2026: 0 articles
Week to 17 May 2026: 2 articles
Week to 10 May 2026: 1 article
Week to 3 May 2026: 1 article
Week to 26 Apr 2026: 1 article
Week to 19 Apr 2026: 0 articles
Week to 12 Apr 2026: 0 articles
Week to 5 Apr 2026: 0 articles
Week to 29 Mar 2026: 4 articles
Week to 22 Mar 2026: 0 articles
Week to 15 Mar 2026: 1 article
Week to 8 Mar 2026: 0 articles
Week to 1 Mar 2026: 0 articles
Week to 22 Feb 2026: 0 articles
Week to 15 Feb 2026: 0 articles
Week to 8 Feb 2026: 0 articles
Week to 1 Feb 2026: 3 articles
Week to 25 Jan 2026: 0 articles
Week to 18 Jan 2026: 1 article
Week to 11 Jan 2026: 3 articles
Week to 4 Jan 2026: 0 articles
Week to 28 Dec 2025: 0 articles
Week to 21 Dec 2025: 2 articles
Week to 14 Dec 2025: 2 articles
Week to 7 Dec 2025: 2 articles
Week to 30 Nov 2025: 0 articles

Top publishers

Who wrote about LENZ Therapeutics in the last 12 months, and their share of its 89 articles.

PublisherArticlesShare
Yahoo Finance finance.yahoo.com1315%
LENZ Therapeutics ir.lenz-tx.com1315%
Seeking Alpha seekingalpha.com1315%
TradingView tradingview.com56%
Investing.com44%
PR Newswire prnewswire.com33%
Simply Wall St simplywall.st33%
Benzinga benzinga.com22%
The Motley Fool fool.com22%
Genetic Engineering and Biotechnology News genengnews.com22%

Latest articles

Newest first, by publish date. Showing 1 to 25 of 114.

PublishedArticlePublisher
20 Nov 2026Tenpoint Therapeutics submits NDS for Yuvezzi presbyopia drop to Health CanadaOptometry Times
20 Nov 2026Tenpoint Therapeutics Announces New Drug Submission to Health Canada for the Treatment of Blurry Close-Up Vision (Presbyopia) in AdultsYahoo Finance
19 Nov 20269 biotechs will cut at least half their California workforcesBioSpace
16 Nov 2026Everest Medicines Limited (1952.HK) Stock Price, News, Quote & HistoryYahoo! Finance Canada
13 Nov 2026LENZ Therapeutics: Don't Be Tempted With This Value Trap (NASDAQ:LENZ)Seeking Alpha
11 Nov 2026Aquestive Therapeutics: My Biotech Investment Framework Now Requires Me To Downgrade AQST To SellSeeking Alpha
4 Nov 2026Monday’s insider trading: Major buys at Rollins, CrowdStrike CEO sells By Investing.comInvesting.com Australia
4 Nov 2026What Explains LENZ Therapeutics (NASDAQ:LENZ) Near USD 3.52 With USD 197.3 Million Cash?kalkine.ca
3 Nov 202612 Health Care Stocks Moving In Tuesday's Intraday Session - Curis (NASDAQ:CRIS), Pasithea TherapeuticsBenzinga
2 Nov 2026At $3.36 a share on average, RA Capital funds sell LENZ Therapeutics (LENZ) stock.Stock Titan
2 Nov 2026RA Capital Management sells $9.13M in Lenz Therapeutics sharesInvesting.com
31 Oct 2026LENZ Therapeutics (LENZ) Falls 12.61% to $3.05 as Shares Test Lower Support - Overvalued Signalshttps://www.siam.in/
30 Oct 2026LENZ Maintained by HC Wainwright & Co. -- Price Target Lowered tGuruFocus
30 Oct 2026LENZ Therapeutics (LENZ) Stock Rallies As Q3 Results Expose Cash BurnYahoo Finance
30 Oct 2026Lenz Therapeutics Reports VIZZ Sales Growth, Announces CEO Transition and Strategic ReorgVisionMonday.com
29 Oct 2026Lenz reports 75% workforce cut, CEO shakeup alongside Q3 earnings updateFierce Pharma
29 Oct 2026LENZ Therapeutics Q3 2026 Earnings Call TranscriptBenzinga
29 Oct 2026LENZ Therapeutics Q3 Earnings Call HighlightsTradingView
29 Oct 2026Earnings call transcript: LENZ Therapeutics misses Q3 2026 estimates as VIZZ growsInvesting.com
29 Oct 2026LENZ Therapeutics, Inc. Stock 12‑Month Price Target Raised to $21.43, Implies 568% UpsideTradingView
29 Oct 2026LENZ Therapeutics Announces Major Restructuring and CEO TransitionThe Globe and Mail
28 Oct 2026LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Misses Revenue EstimatesYahoo Finance
28 Oct 2026LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO SuccessionLENZ Therapeutics
23 Oct 2026RBB Bancorp (RBB) Edges Higher to $26.52 as Buyers Defend Support - Algorithmic Stock Pickshttps://www.siam.in/
22 Oct 2026LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026LENZ Therapeutics

Articles are what our collector stored from Google News (one search per company, every half hour), counted by publish date. A company's usual week is the median of the 26 weeks before the last 7 days. The collector started on 19 Nov 2026: earlier weeks hold only what Google still returned afterwards, so they are thinner, and "vs usual" runs high for most companies until 26 weeks have passed. Compare companies with each other.